Intravenous administration of fosphenytoin: Options for the management of seizures

Neurology

Volumn 46, Issue 6 SUPPL., 1996, Pages

  Ramsay, R Eugene ^a,b,c   DeToledo, John ^a,b  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF MIAMI   (United States)

^c NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FOSPHENYTOIN SODIUM; PHENYTOIN; PROPYLENE GLYCOL;

ANTICONVULSANT THERAPY; CARDIOTOXICITY; CLINICAL TRIAL; CONFERENCE PAPER; DRUG BLOOD LEVEL; DRUG FORMULATION; DRUG SAFETY; EPILEPTIC STATE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; NEUROTOXICITY; PRIORITY JOURNAL; PRURITUS; SEIZURE;

EID: 0030011003     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/wnl.46.6_suppl_1.17s     Document Type: Conference Paper

References (12)

1. Smith RD, Brown BS, Maher RW, Matier WL. Pharmacology of ACC-9653 (phenytoin prodrug). Epilepsia 1989;30(Suppl 2): S15-S21.
2. Tintinalli JE. Pharmacology of cardiovascular drugs. In: Tintinalli JE, ed. A Study Guide in Emergency Medicine, vol. 2. Dallas: American College of Emergency Physicians, 1978:1-90.
3. Earnest MP, Marx JA, Drury LR. Complications of intravenous phenytoin for acute treatment of seizures: recommendations for usage. JAMA 1983;249:762-765.
4. Carducci B, Hedges JR, Beal JC, et al. Emergency phenytoin loading by constant intravenous infusion. Ann Emerg Med 1984;13:1027-1059.
5. Leppik IE, Boucher BA, Wilder BJ, et al. Pharmacokinetics and safety of phenytoin prodrug given IV or IM in patients. Neurology 1990;40:456-460.
6. Eldon MA, Loewen GR, Voightman RE, Holmes GB, Hunt TL, Sedman AJ. Safety, tolerance, and pharmacokinetics of intravenous fosphenytoin. Clin Pharmacol Ther 1993;53:212.
7. Fischer J. Safety and pharmacokinetics of intravenous loading doses of fosphenytoin for the acute treatment of seizures. Presented at the American Epilepsy Society meeting, December 1995.
8. Allen FH Jr, Runge JW, Legarda S, et al. Safety, tolerance, and pharmacokinetics of intravenous fosphenytoin (Cerebyx) in status epilepticus. Epilepsia 1995;36(Suppl 4):90.
9. Cullen JP, Aldrete JA, Kankovsky L, Romo-Salas F. Protective action of phenytoin in cerebral ischemia. Anesth Analg 1979;58:165-169.
10. Boxer PA, Cordon JJ, Mann ME, et al. Comparison of phenytoin with noncompetitive N-methyl-D-aspartate antagonists in a model of focal brain ischemia in rat. Stroke 1990;21(Suppl): 1147-1151.
11. Taft WC, Clifton GL, Blair RE, DeLorenzo RJ. Phenytoin protects against ischemia-produced neuronal cell death. Brain Res 1989;483:143-148.
12. Col J, Col-Debeys C, Lavenne-Pardonage E, et al. Propylene glycol induced heparin resistance during nitroglycerin infusion. Am Heart J 1985;110:711-173.